Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission File No. 000-49654

CirTran Corporation

(Exact name of registrant as specified in its charter)

Nevada		68-0121636
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

6360 S Pecos Road, Suite 8, Las Vegas, NV 89120

(Address of principal executive offices and zip code)

(801) 963-5112

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		None		None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

	Large accelerated filer ☐	Accelerated filer ☐
	Non-accelerated filer☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. As of November 12, 2024, there were 4,945,417shares of common stock, $0.001par value, outstanding.

TABLE OF CONTENTS

Item		Page
	Part I-Financial Information
1	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets as of September 30, 2024 (unaudited) and December 31, 2023 (Audited)	3
	Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2024 and 2023 (unaudited)	4
	Condensed Consolidated Statements of Stockholders' Deficit for the Three and Nine Months Ended September 30, 2024 and 2023 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2024 and 2023 (unaudited)	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
2	Management's Discussion and Analysis of Financial Condition and Results of Operations	16
3	Quantitative and Qualitative Disclosures about Market Risk	18
4	Controls and Procedures	19
	Part II-Other Information
6	Exhibits	19
	Signatures	20

PART I-FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

		September 30, 2024			December 31, 2023
		(Unaudited)			(Audited)
ASSETS
Current assets:
Cash		$	-			$	-
Inventory			691,923				815,612
Deposits on inventory			26,373				26,983
Deposits on inventory - related party			596,253				224,411
Accounts receivable			135,095				21,536
Other current assets			449,063				441,095
Total current assets			1,898,707				1,529,637
Investment in securities at cost			300,000				300,000
Property and equipment, net of accumulated depreciation			15,248				18,925
Total assets		$	2,213,955			$	1,848,562
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable		$	661,641			$	625,848
Liabilities for product returns and credits			59,521				8,701
Short-term advances payable			162,966				172,966
Short-term advances payable - related parties			31,952				21,882
Accrued liabilities			3,139,734				2,889,389
Accrued payroll and compensation expense			5,283,765				5,067,213
Accrued interest, current portion			6,440,492				5,758,603
Convertible debenture, current portion, net of discounts			264,284				264,284
Note payable, current portion			90,000				90,000
Note payable to stockholders			151,833				151,833
Derivative liability			2,072,094				1,296,937
Liabilities from discontinued operations			4,626,279				4,511,075
Total current liabilities:			22,984,561				20,858,731
Deferred tax liability			27,443				55,946
Note payable, net of current portion			643,000				634,636
Convertible debenture, net of current portion, net of discount			2,151,786				2,077,934
Total liabilities			25,806,790				23,627,247
Commitments and contingencies			-				-
Stockholders' deficit:
Common stock, par value $0.001; 100,000,000shares authorized; 4,945,417shares issued and outstanding			4,945				4,945
Additional paid-in capital			37,233,561				37,233,561
Accumulated deficit			(60,831,341	)			(59,017,191	)
Total stockholders' deficit			(23,592,835	)			(21,778,685	)
Total liabilities and stockholders' deficit		$	2,213,955			$	1,848,562

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

		Three Months Ended September 30,			Nine Months Ended September 30,
		2024			2023			2024			2023
Net sales		$	256,070			$	766,512			$	1,075,952			$	1,438,432
Cost of sales			130,072				112,094				456,533				467,811
Gross profit			125,998				654,418				619,419				970,621
Operating expenses
Employee costs			129,743				149,100				380,645				422,902
Selling, general and administrative expenses			218,480				505,169				601,714				794,362
Total operating expenses			348,223				654,269				982,359				1,217,264
Loss from operations			(222,225	)			149				(362,940	)			(246,643	)
Other income (expense)
Interest expense			(190,399	)			(192,487	)			(561,099	)			(562,546	)
Gain on forgiveness of debt			-				-				-				13,000
Gain (loss) on derivative valuation			(448,898	)			25,265				(775,157	)			(19,238	)
Other income			250				-				250				1,124
Total other expense			(639,047	)			(167,222	)			(1,336,006	)			(567,660	)
Net loss from continuing operations			(861,272	)			(167,073	)			(1,698,946	)			(814,303	)
Loss from discontinued operations			(38,681	)			(38,682	)			(115,204	)			(114,784	)
Net loss before income tax			(899,953	)			(205,755	)			(1,814,150	)			(929,087	)
Income tax			-				-				-				-
Net loss		$	(899,953	))		$	(205,755	)		$	(1,814,150	)		$	(929,087	)
Net loss from continuing operations per common share, basic and diluted		$	(0.17	)		$	(0.03	)		$	(0.34	)		$	(0.16	)
Net loss from discontinued operations per common share, basic and diluted		$	(0.01	)		$	(0.01	)		$	(0.02	)		$	(0.02	)
Net loss per common share, basic and diluted		$	(0.18	)		$	(0.04	)		$	(0.36	)		$	(0.18	)
Basic and diluted weighted average common shares outstanding			4,945,417				4,945,417				4,945,417				4,945,417

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023

(Unaudited)

		Common Stock			Additional Paid-in			Accumulated			Total stockholders'
		Shares			Amount			Capital			Deficit			deficit
Balance, December 31, 2023			4,945,417			$	4,945			$	37,233,561			$	(59,017,191	)		$	(21,778,685	)
Net loss			-				-				-				(518,088	)			(518,088	)
Balance, March 31, 2024			4,945,417				4,945				37,233,561				(59,535,279	)			(22,296,773	)
Net loss			-				-				-				(396,109	)			(396,109	)
Balance, June 30, 2024			4,945,417				4,945				37,233,561				(59,931,388	)			(22,692,882	)
Net loss			-				-				-				(899,953	)			(899,953	)
Balance, September 30, 2024			4,945,417			$	4,945			$	37,233,561			$	(60,831,341	)		$	(23,592,835	)

		Common Stock			Additional Paid-in			Accumulated			Total stockholders'
		Shares			Amount			Capital			Deficit			deficit
Balance, December 31, 2022			4,945,417			$	4,945			$	37,233,561			$	(79,305,551	)		$	(42,067,045	)
Net loss			-				-				-				(480,345	)			(480,345	)
Balance, March 31, 2023			4,945,417				4,945				37,233,561				(79,785,896	)			(42,547,390	)
Net loss			-				-				-				(242,987	)			(242,987	)
Balance, June 30, 2023			4,945,417				4,945				37,233,561				(80,028,883	)			(42,790,377	)
Net loss			-				-				-				(205,755	)			(205,755	)
Balance, September 30, 2023			4,945,417			$	4,945			$	37,233,561			$	(80,234,638	)		$	(42,996,132	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

		For the Nine Months Ended September 30,
		2024			2023
Cash flows from operating activities
Net loss		$	(1,814,150	)		$	(929,087	)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:
Loss from discontinued operations			115,204				114,784
Depreciation expense			3,677				3,260
Loss on derivative valuation			775,157				19,238
Debt discount amortization			73,852				71,551
Gain on settlement of debt			-				(13,000	)
Changes in operating assets and liabilities:
Inventory			123,689				(58,244	)
Deposits on inventory			610				(25,000	)
Deposits on inventory - related party			(371,842	)			325,458
Accounts receivable			(113,559	)			(94,749	)
Other current assets			(7,968	)			(247,917	)
Accounts payable			35,793				21,323
Liabilities for product returns and credits			50,820				108,461
Accrued liabilities			250,345				158,670
Income tax liability			(28,503	)			-
Accrued payroll and compensation			216,552				233,457
Accrued interest			681,889				344,803
Net cash (used) provided by operating activities			(8,434	)			33,008
Cash flows from investing activities:
Purchase of property and equipment			-				(8,414	)
Net Cash used in investing activities			-				(8,414	)
Cash flows from financing activities:
Repayments of loans payable					-
Proceeds from loans payable			-				65,925
Proceeds from related-party loans			8,434				13,858
Repayments of related-party loans			-				(99,056	)
Net Cash provided (used) by financing activities			8,434			(19,273	)
Net change in cash			-				5,321
Cash, beginning of period			-				18,081
Cash, end of period		$	-			$	23,402
Supplemental disclosure of cash flow information:
Cash paid for interest		$	-			$	-
Cash paid for income taxes		$	-			$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

CIRTRAN CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2024

NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS

In 1987, CirTran Corporation was incorporated in Nevada under the name Vermillion Ventures, Inc., for the purpose of acquiring other operating corporate entities. We were largely inactive until July 1, 2000, when our wholly owned subsidiary, CirTran Corporation (Utah), acquired substantially all the assets and certain liabilities of Circuit Technology, Inc., founded by our president, Iehab Hawatmeh.

We, together with our majority-owned subsidiaries, manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name. Since entering our 2019 five-year manufacturing and distribution agreement with an unrelated party, our efforts have been devoted to phase one of our development of all HUSTLER®-branded products, which led us to generating revenue during 2020 for the first time in several years.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in our Form 10-K for the fiscal year ended December 31, 2023. In the opinion of our management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position, as of September 30, 2024, and the results of our operations and cash flows for the nine months then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year ending December 31, 2024.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.

Principles of Consolidation

The consolidated financial statements include the accounts of the company and our wholly owned subsidiaries: CirTran Products Corp., LBC Products, Inc., and CirTran Asia, Inc. Intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

In preparing the financial statements in accordance with US GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.

Concentrations of Credit Risk

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may exceed the Federal Deposit Insurance Corporation insurable limit.

Cash Equivalents

We consider all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were nocash equivalents as of September 30, 2024 and December 31, 2023.

Revenue Recognition

We follow Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers, for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial statements. We generate revenue by providing product design services and through the sales of tangible product. We recognize revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to be received in exchange for those products or services. We determine the transaction price associated with each deliverable based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

During the nine months ended September 30, 2024 and 2023, we recognized revenue of $68,709and $538,228, respectively, related to the performance obligations under product development service agreements with customers. These contracts are long term in nature and revenue is recognized at certain milestone intervals upon our delivery and customer acceptance of work product related to those milestones: namely, product design, packaging, branding display, and prototypes. There were no costs to obtain the contracts identified, and therefore, no asset has been recorded for customer acquisition costs. We have not recognized impairment losses related to the receivables from these contracts during the nine months ended September 30, 2024 and 2023.

Additionally, we recognized revenues of $1,007,243and $900,204during the nine months ended September 30, 2024 and 2023, respectively, related to the delivery of products to our customers. Each delivery is based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Upon acceptance, we oblige delivery of such product to the customer at an agreed-upon place, time, and price. We recognize revenue under the unique contract upon fulfillment of our performance obligations therein, typically limited to the delivery of product.

The Company also recognizes revenue from advanced royalty payments per the terms in its Manufacturing and Distribution Agreement with one of its distributors. The royalty to be received is calculated based on 8% of gross sales, with an annual minimum royalty paid upfront per calendar year for the term of the contract. There is a non-refundable $350,000Minimum Royalty for FY 2023. The Company recognizes the minimum royalty and corresponding expense at the time of receipt.

Accounts Receivable

Revenues that have been recognized but not yet received are recorded as accounts receivable. The Company estimates credit losses based on the Current Expected Credit Losses (CECL) model as required by ASC 326. The allowance for credit losses is based on a variety of factors, including historical loss experience, current conditions, and reasonable and supportable forecasts of future economic conditions. As of September 30, 2024 and December 31, 2023, the Company has notrecorded an allowance for doubtful accounts.

Investment in Securities

Our cost-method investment consists of an investment in a private digital multi-media technology company that totaled $300,000at September 30, 2024 and December 31, 2023. Because we owned less than 20% of that company's stock as of each date, and no significant influence or control exists, the investment is accounted for using the cost method. Pursuant to ASC 321, the Company also searched for observable transactions in the investee's stock and found none.

We evaluated the investment for impairment and determined there was none during the periods presented.

Inventories

Inventories are stated at the lower of average cost or net realizable value. Cost on manufactured inventories includes labor, material, and overhead. Overhead cost is based on indirect costs allocated to cost of sales, work-in-process inventory, and finished goods inventory. Indirect overhead costs have been charged to cost of sales or capitalized as inventory, based on management's estimate of the benefit of indirect manufacturing costs to the manufacturing process.

When there is evidence that the inventory's value is less than original cost, the inventory is reduced to market value. We determine market value on current resale amounts and whether technological obsolescence exists. We will seek agreements with manufacturing customers that require them to purchase their inventory items in the event they cancel their business with us.

From time to time, we will place deposits on inventory to be delivered in the future. These deposits are carried as a separate balance sheet component and total $26,373(non-related-party) and $596,253(related-party) as of September 30, 2024 and $26,983(non-related-party) and $224,411(related-party) as of December 31, 2023.

On most of tobacco related products, the Company pays in advance for Federal Excise Taxes and State Excise Taxes prior to receiving product. The Company accrues those taxes on its balance sheet and expenses them per-unit basis as sold.

Inventory balances consisted of the following:

		September 30, 2024			December 31, 2023
Finished goods		$	644,978			$	772,589
Raw materials			46,945				43,023
Total		$	691,923			$	815,612

Fair Value of Financial Instruments

ASC 820-10-15, Fair Value Measurement-Overall-Scope and Scope Exceptions, defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:

Level 1-Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2-Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3-Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Accounts payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these instruments. Derivative liabilities are measured using level 3 inputs.

		Total Fair Value at September 30, 2024			Quoted prices in active markets (Level 1)			Significant other observable inputs (Level 2)			Significant unobservable inputs (Level 3)
Derivative liabilities		$	2,072,094			$	-			$	-			$	2,072,094

		Total Fair Value at December 31, 2023			Quoted prices in active markets (Level 1)			Significant other observable inputs (Level 2)			Significant unobservable inputs (Level 3)
Derivative liabilities		$	1,296,937			$	-			$	-			$	1,296,937

Loss per Share

Basic loss per share is calculated by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during each period. Diluted loss per share is similarly calculated, except that the weighted-average number of common shares outstanding would include common shares that may be issued subject to existing rights with dilutive potential when applicable. There were approximately 402,678,000and 216,834,000potentially issuable shares from the conversions of convertible debentures outstanding that were excluded in dilutive outstanding shares for the nine months ended September 30, 2024 and 2023, respectively, due to the anti-dilutive effect these would have on net loss per share. We do not currently have adequate authorized but unissued shares to satisfy our obligations should all instruments eligible to convert to common stock be exercised. We are not currently contemplating an increase in our authorized shares but may do so in the future.

Recently Issued Accounting Pronouncements

The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its Consolidated Financial Statements and assures that there are proper controls in place to ascertain that the Company's Consolidated Financial Statements properly reflect the change.

NOTE 3 - GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared in conformity with US GAAP, which considers our continuation as a going concern. We had a working capital deficiency of $21,085,854as of September 30, 2024, and a net loss from continuing operations of $1,698,946for the nine months ended September 30, 2024. As of September 30, 2024, we had an accumulated deficit of $60,831,341. These conditions raise substantial doubt about our ability to continue as a going concern.

Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan and eventually attain profitable operations. The accompanying unaudited consolidated financial statements do not include any adjustments that may be necessary if we are unable to continue as a going concern.

In the coming year, our foreseeable cash requirements will relate to development of business operations and associated expenses. We may experience a cash shortfall and be required to raise additional capital.

Historically, we have mainly relied upon shareholder loans and advances to finance operations and growth. Management may raise additional capital by retaining net earnings, if any, or through future public or private offerings of our stock or loans from private investors, although we cannot assure that we will be able to obtain such financing. Our failure to do so could have a material and adverse effect upon our shareholders and us.

NOTE 4 - PROPERTY AND EQUIPMENT

We incur certain costs associated with the design and development of molds and dies for our contract-manufacturing segment. These costs are held as deposits on the balance sheet until the molds or dies are finished and ready for use. At that point, the costs are included as part of production equipment in property and equipment and are amortized over their useful lives. We hold title to all molds and dies used in the manufacture of products.

Property and equipment and estimated service lives consist of the following:

		September 30, 2024			December 31, 2023			Useful Life (years)
Furniture and office equipment		$	12,212			$	12,212			5-10
Vehicles			18,672				18,672			3-7
Total			30,884				30,884
Less: accumulated depreciation			(15,636	)			(11,959	)
Property and equipment, net		$	15,248			$	18,925

We recorded $3,677and $3,260of depreciation expense during the nine months ended September 30, 2024 and 2023.

NOTE 5 - RELATED PARTY TRANSACTIONS

In 2007, we issued a 10% promissory note to a family member of our president in exchange for $300,000. The note was due on demand after May 2008. There were no repayments made during the periods presented. At September 30, 2024 and December 31, 2023, the principal amount owing on the note was $151,833and $151,833, respectively. No demand for payment has been made.

On March 31, 2008, we issued to this same family member, along with two other company shareholders, promissory notes totaling $315,000($105,000each). Under the terms of these three $105,000notes, we received total proceeds of $300,000and agreed to repay the amount received plus a 5% borrowing fee. The notes were due April 30, 2008, after which they were due on demand, with interest accruing at 12% per annum. We made no payments towards the outstanding notes during the periods presented. The principal balance owing on the notes as of September 30, 2024 and December 31, 2023, was $72,466and $72,466, respectively. No demand for payment has been made.

There were $21,882and $21,882of short-term advances due to related parties as of September 30, 2024 and December 31, 2023, respectively.

We have agreed to issue stock options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive officer. The terms of his employment agreement require us to grant options to purchase 6,000shares of our stock each year. Mr. Hawatmeh held outstanding options to purchase 24,000shares of common stock as of September 30, 2024. See Note 11-Stock Options and Warrants.

As of September 30, 2024 and December 31, 2023, we owed our president a total of $433,379and $433,379, respectively, in unsecured advances. The advances and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by our president on these loans. These amounts are included in our liabilities from discontinued operations.

During the nine months ended September 30, 2024, we had a net decrease in deposits with a related-party inventory supplier totaling $371,842. The related party is an entity controlled by our chief executive officer. All transactions were at a 2% markup over the related-party's cost paid for inventory in arm's-length transactions. Total inventory purchases from the related party were $731,918and $837,618during the periods ended September 30, 2024 and December 31, 2023, respectively.

NOTE 6 - OTHER ACCRUED LIABILITIES

Accrued tax liabilities consist of delinquent payroll taxes, interest, and penalties owed by us to the Internal Revenue Service ("IRS") and other tax entities.

Accrued liabilities consist of the following:

		September 30, 2024			December 31, 2023
Tax liabilities		$	46,203			$	37,228
Accrued Royalty - Globrands LLC			1,016,256				1,092,915
Other			2,077,275				1,759,246
Total		$	3,139,734			$	2,889,389

Other accrued liabilities as of September 30, 2024 and December 31, 2023, include a non-interest-bearing payable totaling $45,000and $45,000, respectively, that is due on demand and customer deposits totaling $2,064,335and $1,735,109, respectively.

Accrued payroll and compensation liabilities consist of the following:

		September 30, 2024			December 31, 2023
Director fees		$	140,000			$	135,000
Bonus expenses			129,358				121,858
Commissions			2,148				2,148
Consulting			412,322				438,822
Administrative payroll			4,599,937				4,369,385
Total		$	5,283,765			$	5,067,213

NOTE 7 - COMMITMENTS AND CONTINGENCIES

Litigation and Claims

Various vendors, service providers, and others have asserted legal claims in previous years. These creditors generally are not actively seeking collection of amounts due to them, and we have determined that the probability of realizing any loss on these claims is remote and will seek to compromise and settle at a deep discount any of such claims that are asserted for collection. These amounts are included in our current liabilities, except where we believe collection or enforcement of the judgments is barred by the applicable statute of limitations, in which case the liabilities have been eliminated. We have not accrued any liability for claims or judgments that we have determined to be barred by the applicable statute of limitations, which generally is eight years for judgments in Utah.

Playboy Enterprises, Inc.

Our affiliate, Play Beverages, LLC, filed suit against Playboy Enterprises, Inc., in Cook County, Illinois, Circuit Court in October 2012 asserting numerous claims, including breach of contract and tortious interference. Playboy responded with a counterclaim of breach of contract and trademark infringement. After proceedings in October 2016, the court awarded a judgment of $6.6million to Playboy against Play Beverages and CirTran Beverage Corp., our subsidiary. The court denied our motion for a new trial and awarded Playboy treble patent infringement damages and attorney's fees. We filed a notice of appeal in July 2017 and again in March 2018. Playboy has initiated collection efforts but has recovered no funds. In September 2018, the appellate court affirmed the judgment of the circuit court. The balance due related to this judgment, has been included in liabilities in discontinued operations. As of December 31, 2023, the Company received legal representation that the judgement can no longer be enforced after seven years, as a result, the Company has recognized a gain from discontinued operations of $18,878,359of time barred debt previously included in liabilities from discontinued operations.

Delinquent Payroll Taxes, Interest, and Penalties

In November 2004, the IRS accepted our amended offer in compromise (the "Offer") to settle delinquent payroll taxes, interest, and penalties, which required us to pay $500,000, remain current in our payment of taxes for five years, and forego claiming any net operating losses for the years 2001 through 2015 or until we paid taxes on future profits in an amount equal to the taxes of $1,455,767waived by the Offer. In June 2013, we entered into a partial installment agreement to pay $768,526in unpaid 2009 payroll taxes, which required us to pay the IRS 5% of cash deposits. The monthly payments were to continue until the account balances were paid in full or until the collection statute of limitation expired on October 6, 2020. We are currently in communication with the IRS regarding the statute of limitations on this settlement and appropriate next steps. During the year ended December 31, 2023, the Company wrote off $512,520as time barred debt. The amounts of $5,164and $5,164were due as September 30, 2024 and December 31, 2023, respectively.

Employment Agreements

We engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended in September 2017. In July 2017, Mr. Hawatmeh had resigned all positions with us to pursue other business activities, thereby effectively terminating the agreement. However, the amendment to his employment agreement in September 2017 reinstated Mr. Hawatmeh to his previous positions, with a salary in an amount to be determined. Among other things, the reinstated employment agreement: (a) grants options to purchase a minimum of 6,000shares of our stock each year, with an exercise price equal to the market price of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus approved by our board; and (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5% of our earnings before interest, taxes, depreciation, and amortization for the applicable quarter; (ii) bonuses equal to 1% of the net purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus (payable quarterly) equal to 1% of our gross sales of all products, net of returns and allowances. On January 1, 2020, we resumed accruing wages for our chief executive officer. A total of $222,373and $345,000was accrued during the periods ended September 30, 2024 and December 31, 2023, respectively.

We also have an oral agreement with our other director that requires us to issue options to purchase 2,000 shares of our common stock each year.

License Agreements

We have entered into agreements requiring us to pay certain royalties for the manufacture and distribution of licensed products. Fees are based on a percentage of sales and remitted quarterly and are included in cost of sales for financial reporting purposes.

NOTE 8 - NOTES PAYABLE

Notes payable consisted of the following:

		September 30, 2024			December 31, 2023
Note payable to former service provider for past due account payable (current)		$	90,000			$	90,000
Note payable for settlement of debt (long-term)			500,000				500,000
Small Business Administration loans			143,000				134,636
Total		$	733,000			$	724,636

There is $383,327and $366,626of accrued interest due on these notes as of September 30, 2024 and December 31, 2023, respectively.

NOTE 9 - CONVERTIBLE DEBENTURES

Convertible debentures consisted of the following:

		September 30, 2024			December 31, 2023
Convertible debenture, 5% stated interest rate, secured by all our assets, due on May 30, 2022		$	200,000			$	200,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on February 8, 2022			25,000				25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on May 30, 2022			25,000				25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on December 8, 2022			25,000				25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on April 30, 2027			2,390,528				2,390,528
Subtotal		$	2,665,528			$	2,665,528
Less: discounts			(249,458	)			(323,310	)
Total		$	2,416,070			$	2,342,218
Less: current portion			(264,284	)			(264,284	)
Long-term portion		$	2,151,786			$	2,077,934

The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100or the lowest bid price for the 20trading days prior to conversion.

As of September 30, 2024 and December 31, 2023, we had accrued interest on the convertible debentures totaling $2,021,639and $1,921,590, respectively.

NOTE 10 - DERIVATIVE LIABILITIES

As discussed in Note 9-Convertible Debentures, we have entered into five separate agreements to borrow a total of $2,665,528with the outstanding principal and interest being convertible at the holder's option into common stock of the company at the lesser of $100(notes one through four) or $0.10 (note five) or the lowest closing bid price in the prior 20 trading days.Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in our balance sheet. We measure these instruments at their estimated fair value and recognize changes in their estimated fair value in results of operations during the period of change. We have estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a Monte Carlo simulation as of September 30, 2024, using the following assumptions:

Volatility			139.3% - 142.2	%
Risk-free rates			4.09% - 4.13	%
Stock price		$	0.006
Remaining life			0.25- 2.58years

A summary of the activity of the derivative liability for these notes is as follows:

Balance at December 31, 2022		$	1,004,837
Derivative loss due to mark to market adjustment			292,100
Balance at December 31, 2023			1,296,937
Derivative loss due to mark to market adjustment			775,157
Balance at September 30, 2024		$	2,072,094

The fair values of the derivative instruments are measured each quarter, which resulted in a loss of $775,157and $19,238during the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024 and December 31, 2023, the fair market value of the derivatives aggregated $2,072,094and $1,296,937, respectively.

NOTE 11 - STOCK OPTIONS AND WARRANTS

Stock Incentive Plans

As of September 30, 2024 and December 31, 2023, we had nounrecognized compensation related to outstanding options that have not yet vested at year-end that would be recognized in subsequent periods.

As of September 30, 2024 and December 31, 2023, there were 32,000options issued and vested with a weighted average exercise price of $0.01and a weighted average remaining life of 2.23years. Outstanding options as of September 30, 2024, consisted of:

Exercise Price			Count			Average Exercise			Remaining Life			Exercisable
$	0.01				32,000				0.01				2.23				32,000

NOTE 12-DISCONTINUED OPERATIONS

At October 21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this business are displayed as assets and liabilities from discontinued operations as of September 30, 2024 and December 31, 2023. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations.

During the year ended December 31, 2023, the Company received legal representation that the judgement related to Play Beverages, LLC, (Note 7) can no longer be enforced after seven years, as a result, the Company has recognized a gain from discontinued operations of $18,873,932of time barred debt previously included in liabilities from discontinued operations.

Total assets and liabilities included in discontinued operations were as follows:

		September 30, 2024			December 31, 2023
Assets from Discontinued Operations:
Cash		$	-			$	-
Total assets from discontinued operations		$	-			$	-
Liabilities from Discontinued Operations:
Accounts payable		$	283,818			$	283,818
Accrued liabilities			58,184				58,184
Accrued interest			1,751,828				1,636,624
Accrued payroll and compensation expense			122,864				122,864
Current maturities of long-term debt			239,085				239,085
Short-term advances payable			2,170,500				2,170,500
Total liabilities from discontinued operations		$	4,626,279			$	4,511,075

Net loss from discontinued operations for the nine months ended September 30, 2024 and 2023, were comprised of the following components:

		Nine Months ended September 30,
		2024			2023
Other expense:
Interest expense			(115,204	)			(114,784	)
Net loss from discontinued operations		$	(115,204	)		$	(114,784	)

NOTE 13 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10), management has performed an evaluation of subsequent events through the date that the unaudited consolidated financial statements were issued and has determined that it does not have any material subsequent events to disclose in these unaudited consolidated financial statements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our condensed consolidated unaudited financial statements and notes to our unaudited financial statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors discussed elsewhere in this report.

Overview

Based on our diversified expertise in manufacturing, marketing, distribution, and technology services in a wide variety of consumer products, including tobacco products, medical devices, and beverages, around the world, we have an innovative and consumer-focused approach to brand portfolio management, resting on a strong understanding of consumers domestically, and we have established a footprint in more than 50 key, international markets.

Since 2021, we continue under our 2019 five-year manufacturing and distribution agreement with an unrelated party to manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name.

Results of Operations for the Three Months Ended September 30, 2024, Compared to the Three Months Ended September 30, 2023

Sales and Cost of Sales

During the three months ended September 30, 2024 and 2023, we had net sales of $256,070 and $766,512, respectively, a decrease of $510,422 or 66.6%. We had cost of sales of $130,072 and $112,094, respectively, and gross profit of $125,998 and $654,418, respectively. Revenues are derived from the design, manufacture, and delivery of certain licensed products in accordance with our GloBrands-HUSTLER® distribution agreement. We had higher revenue in the prior period due to additional income from the licensing of novelties in an international territory.

Operating Expenses

During the three months ended September 30, 2024 and 2023, employee costs were $129,743 and $149,100 respectively, a decrease of $19,357 or 13%. Employee costs decreased in the current period due to efficiencies based on the current business level.

During the three months ended September 30, 2024 and 2023, selling, general, and administrative expenses ("S,G&A") were $218,480 and $505,169, respectively, a decrease of $286,689 or 56.8%. The decrease in S,G&A expenses period over period was the result of a reduction in spending on marketing.

Other Expense

Total other expense during the three months ended September 30, 2024 was $639,047 compared to $167,222 for the prior period. In the current period we had $190,399 of interest expense and a loss of $448,898 on derivative valuation. We also had other income of $250. In the prior period we had $192,487 of interest expense and a gain of $25,265 on derivative valuation.

Net Loss

Our net loss from continuing operations for the three months ended September 30, 2024, was $861,272 compared to $167,073 for the three months ended September 30, 2023, an increase to our net loss of $694,199. Our net loss increased in the current period due to the reasons discussed above.

Results of Operations for the Nine Months Ended September 30, 2024, Compared to the Nine Months Ended September 30, 2023

Sales and Cost of Sales

During the nine months ended September 30, 2024 and 2023, we had net sales of $1,075,952 and $1,438,432, respectively, a decrease of $362,480 or 25.2%. We had cost of sales of $456,533 and $467,811, respectively, for gross profit of $619,419 and $970,621, respectively. Revenues are derived from the design, manufacture, and delivery of certain licensed products in accordance with our GloBrands-HUSTLER® distribution agreement. We had higher revenue in the prior period due to additional income from the licensing of novelties in an international territory.

Operating Expenses

During the nine months ended September 30, 2024 and 2023, employee costs were $380,645 and $422,902 respectively, a decrease of $42,257 or 10%. Employee costs decreased in the current period due to efficiencies based on the current business level.

During the nine months ended September 30, 2024 and 2023, S,G&A costs were $601,714 and $794,362, respectively, a decrease of $192,648 or 24.3%. The decrease in S,G&A expenses period over period was the result of a reduction in spending on marketing.

Other Expense

Total other expense during the nine months ended September 30, 2024 was $1,336,006 compared to $567,660 for the prior period. In the current period we had $561,099 of interest expense and a loss of $775,157 on derivative valuation. We also had other income of $250. In the prior period we had $562,546 of interest expense, a loss of $19,238 on derivative valuation, a gain on forgiveness of debt of $13,000 and other income of $1,124.

Net Loss

Our net loss from continuing operations for the nine months ended September 30, 2024, was $1,698,946 compared to $814,303 for the nine months ended September 30, 2023, an increase to our net loss of $884,643 Our net loss increased in the current period due to the reasons discussed above.

Liquidity and Capital Resources

We have had a history of losses from operations, as our expenses have been greater than our revenue. Our accumulated deficit was approximately $60.8 million at September 30, 2024. As of September 30, 2024, we had current assets of $2 million and current liabilities of approximately $23 million, resulting in a working capital deficit of approximately $21 million at September 30, 2024.

Operating Activities

During the nine months ended September 30, 2024, operations used $8,434 of net cash, comprised of a loss of $1,814,150, noncash items totaling $967,890 consisting primarily of losses recognized from the changes in fair values of derivative liabilities and debt discount amortization, and changes in working capital totaling $837,826. During the nine months ended September 30, 2023, operations provided $33,008 of net cash, comprised of a loss of $929,087, noncash items totaling $195,833 consisting primarily of losses recognized from the changes in fair values of derivative liabilities and debt discount amortization, and changes in working capital totaling $837,826.

Investing Activities

There were no investing activities during the nine months ended September 30, 2024. During the nine months ended September 30, 2023, we used $8,414 for investing activities for the purchase of equipment.

Financing Activities

During the nine months ended September 30, 2024, financing activities provided $8,434 of cash, compared to using $19,273 of cash during the nine months ended September 30, 2023. Cash used in financing consisted of repayments of loans.

Our Capital Resources and Anticipated Requirements

Our monthly operating costs are approximately $35,000 per month, excluding approximately $50,000 of accruing interest expense and capital expenditures. We continue to focus on generating revenue and reducing our monthly business expenses through cost reductions and operational streamlining. We have only recently begun to generate enough cash to sustain our day-to-day operations, and we expect to access external capital resources in the future to fund any new projects we may undertake. We cannot assure that we will be successful in obtaining such capital.

If we seek infusions of capital from investors, it is unlikely that we will be able to obtain additional debt financing. If we did incur additional debt, we would be required to devote additional cash flow to servicing the debt and securing the debt with assets.

Our issuance of additional shares for equity or for conversion of debt could dilute the value of our common stock and existing stockholders' positions.

Convertible Debentures and Note Payable

We currently have an outstanding amended, restated, and consolidated secured convertible debenture with Tekfine, LLC, an unrelated entity, with a maturity date of April 30, 2027, to the extent not previously converted. The amended debenture had a total outstanding principal balance of $2.4 million, with accrued interest of $2 million as of September 30, 2024. We also have four additional convertible debentures with Tekfine with maturity dates ranging from December 8, 2022, until December 30, 2022, totaling $275,000, unless earlier converted. The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100 or $0.10 (depending on the instrument) or the lowest bid price for the 20 trading days prior to conversion.

As of September 30, 2024, there is $21,882 of short-term advances due to related parties. The advances are due on demand and included in current liabilities. No demand for payment has been made.

Going Concern

These interim unaudited financial statements have been prepared on the going concern basis, which assumes that adequate sources of financing will be obtained as required and that our assets will be realized and liabilities settled in the ordinary course of business. Accordingly, the interim unaudited financial statements do not include any adjustments related to the recoverability of assets and classification of assets and liabilities that might be necessary should we not be unable to continue as a going concern.

Critical Accounting Policies

We have identified the policies outlined below as critical to our business operations and an understanding of our results of operations. Refer to Note 2 - Summary of Significant Accounting Policies for discussion.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to provide the information required by this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of September 30, 2024, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive and financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures were not effective as of September 30, 2024, to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the periods prescribed by U.S. Securities and Exchange Commission and that such information is accumulated and communicated to management, including our chief executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure.

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended September 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II-OTHER INFORMATION

ITEM 6. EXHIBITS

The following exhibits are filed as a part of this report:

Exhibit Number*		Title of Document		Location
Item 31		Rule 13a-14(a)/15d-14(a) Certifications
31.01		Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14		This filing.
Item 32		Section 1350 Certifications
32.01		Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002		This filing.
Item 101		Interactive Data File
101.INS		Inline XBRL Instance Document		This filing.
101.SCH		Inline XBRL Taxonomy Extension Schema		This filing.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase		This filing.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase		This filing.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase		This filing.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase		This filing.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*

All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the document's sequence.

**

The XBRL related information in Exhibit 101 will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and will not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as is expressly set forth by specific reference in such filing or document.

SIGNATURE PAGE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CIRTRAN CORPORATION
Dated: November 14, 2024	By:	/s/ Iehab Hawatmeh
		Iehab Hawatmeh, President
		Principal Executive and Financial Officer

Public link

Please use the above public link if you want to share this noodl on another website.